Coronary Artery Disease (CAD)
A prospective study to compare the diagnostic performance of FFRct and SPECT in subjects with suspected stable coronary artery disease after abnormal SPECT imaging who have no contraindictions to coronary CTA (cCTA).
Principal Investigator: David L. Brown, MD
Locations: Baylor Scott & White The Heart Hospital – Plano, The Heart Group Plano, The Heart Group McKinney, Legacy Heart Center Plano, Legacy Heart Center McKinney, Baylor Scott & White The Heart Hospital – Denton
IRB Number: 016-096
Trial Status: Enrolling
Exclusions: Adults only
Change in Care: During cath, if physician suspects visual stenosis of 50-89%, FFR will be performed
Julie McCracken, CCRC469.814.4717Julie.McCracken@BSWHealth.org
Heath Shirkey, RN469.814.4185Heath.Shirkey@BSWHealth.org
Assessment of Fractional Flow reservE Computed Tomography Versus Single Photon Emission Computed Tomography in the Diagnosis of Hemodynamically Significant Coronary Artery Disease. (AFFECTS)
Get Detailed Information On Clinicaltrials.gov »
Physicians are members of the medical staff at one of Baylor Scott & White Health's subsidiary, community or affiliated medical centers and are neither employees nor agents of those medical centers, Baylor Scott & White The Heart Hospital – Plano or Baylor Scott & White Health.